ASX:COH - Cochlear Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$233.00 +4.79 (+2.10 %) (As of 02/16/2020 02:02 PM ET) Add Compare Today's RangeA$228.20Now: A$233.00▼A$233.9050-Day RangeA$224.02MA: A$235.10▼A$244.7652-Week RangeA$164.00Now: A$233.00▼A$244.99Volume223,318 shsAverage Volume194,422 shsMarket Capitalization$13.47 billionP/E Ratio48.59Dividend Yield1.36%BetaN/A ProfileAnalyst RatingsAdvanced ChartDividendEarningsInsider TradesHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. Read More… Industry, Sector and Symbol Stock Exchange ASX Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolASX:COH Previous Symbol CUSIPN/A CIKN/A Webhttp://www.cochlear.com/ Phone+61-2-94286555Debt Debt-to-Equity Ratio25.02 Current Ratio1.77 Quick Ratio1.14Price-To-Earnings Trailing P/E Ratio48.59 Forward P/E Ratio46.79 P/E GrowthN/A Sales & Book Value Annual Sales$1.43 billion Price / Sales9.44 Cash FlowA$1.30 per share Price / Cash Flow178.58 Book ValueA$12.58 per share Price / Book18.53Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees3,500 Outstanding Shares57,829,100Market Cap$13.47 billion Next Earnings Date2/19/2020 (Estimated) OptionableOptionable Receive COH News and Ratings via Email Sign-up to receive the latest news and ratings for COH and its competitors with MarketBeat's FREE daily newsletter. Cochlear (ASX:COH) Frequently Asked Questions What is Cochlear's stock symbol? Cochlear trades on the ASX under the ticker symbol "COH." How often does Cochlear pay dividends? What is the dividend yield for Cochlear? Cochlear announced a Final dividend on Tuesday, August 20th. Stockholders of record on Monday, October 14th will be given a dividend of 1.75 per share on Monday, October 14th. This represents a dividend yield of 0.8%. The ex-dividend date is Thursday, September 19th. View Cochlear's Dividend History. How were Cochlear's earnings last quarter? Cochlear Limited (ASX:COH) posted its earnings results on Tuesday, February, 19th. The company reported $2.15 EPS for the quarter, missing analysts' consensus estimates of $2.19 by $0.04. View Cochlear's Earnings History. When is Cochlear's next earnings date? Cochlear is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Cochlear. Has Cochlear been receiving favorable news coverage? News coverage about COH stock has been trending neutral on Sunday, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cochlear earned a coverage optimism score of 0.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Cochlear. Who are some of Cochlear's key competitors? Some companies that are related to Cochlear include Fisher & Paykel Healthcare (FPH), ConvaTec Group (CTEC), Avita Medical (AVH), Stratec (SBS), Draegerwerk AG & Co KGaA (DRW3), Zynex (ZYXI), Creo Medical Group (CREO), Medica Group (MGP), Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), Hamilton Thorne (HTL), Cyclopharm (CYC), Electromed (ELMD), MRI Interventions (MRIC), Advanced Oncotherapy (AVO) and Electromed (ELMD). What other stocks do shareholders of Cochlear own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cochlear investors own include iShares Core S&P 500 ETF (IVV), ResMed (RMD), Alumina (AWC), CSL (CSL), Nufarm (NUF), REA Group (REA), TPG Telecom (TPM), Janus Henderson Group (HGG), Mesoblast (MESO) and Omnicell (OMCL). Who are Cochlear's key executives? Cochlear's management team includes the folowing people: Mr. Diggory William Howitt, CEO, MD, Pres & Exec. Director (Age 52)Mr. Brent Andrew Cubis, Chief Financial OfficerMr. Jan Janssen, Chief Technology OfficerMr. Richard Brook, Pres of EMEA & Latin American RegionMr. Anthony Manna, Pres of Americas Region What is Cochlear's stock price today? One share of COH stock can currently be purchased for approximately A$233.00. How big of a company is Cochlear? Cochlear has a market capitalization of $13.47 billion and generates $1.43 billion in revenue each year. Cochlear employs 3,500 workers across the globe.View Additional Information About Cochlear. What is Cochlear's official website? The official website for Cochlear is http://www.cochlear.com/. How can I contact Cochlear? Cochlear's mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company can be reached via phone at +61-2-94286555. MarketBeat Community Rating for Cochlear (ASX COH)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 157 (Vote Outperform)Underperform Votes: 244 (Vote Underperform)Total Votes: 401MarketBeat's community ratings are surveys of what our community members think about Cochlear and other stocks. Vote "Outperform" if you believe COH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/16/2020 by MarketBeat.com StaffFeatured Article: What are the benefits of investing in REITs?
